Andrew Hall
Chief Executive Officer bij IMV INC.
Vermogen: 12 $ op 31-12-2023
Actieve functies van Andrew Hall
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IMV INC. | Director/Board Member | 01-01-2022 | - |
| Chief Executive Officer | 04-08-2021 | - | |
| Corporate Officer/Principal | 10-11-2020 | 04-08-2021 |
Loopbaan van Andrew Hall
Eerdere bekende functies van Andrew Hall
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | - | - |
| CELGENE | Corporate Officer/Principal | - | - |
Opleiding van Andrew Hall
| University of Melbourne | Undergraduate Degree |
| RMIT University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Australië | 3 |
| Canada | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| IMV INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Beurs
- Insiders
- Andrew Hall
- Ervaring
